Voyager Therapeutics Inc
NASDAQ:VYGR

Watchlist Manager
Voyager Therapeutics Inc Logo
Voyager Therapeutics Inc
NASDAQ:VYGR
Watchlist
Price: 3.09 USD -0.64% Market Closed
Market Cap: 170.6m USD

Intrinsic Value

VYGR's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one VYGR stock under the Base Case scenario is 4.62 USD. Compared to the current market price of 3.09 USD, Voyager Therapeutics Inc is Undervalued by 33%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VYGR Intrinsic Value
4.62 USD
Undervaluation 33%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Voyager Therapeutics Inc

VYGR
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for VYGR cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Voyager Therapeutics Inc
NASDAQ:VYGR
US
Biotechnology
Market Cap
169.1m USD
IPO
Nov 11, 2015
US
Biotechnology
Market Cap
169.1m USD
IPO
Nov 11, 2015
Price
$false
EPS
$false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about VYGR?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Voyager Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Voyager Therapeutics Inc

Current Assets 276.8m
Cash & Short-Term Investments 266.7m
Receivables 2.2m
Other Current Assets 7.9m
Non-Current Assets 116.2m
Long-Term Investments 65.7m
PP&E 47.7m
Other Non-Current Assets 2.9m
Efficiency

Free Cash Flow Analysis
Voyager Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Voyager Therapeutics Inc

Revenue
80m USD
Operating Expenses
-160.5m USD
Operating Income
-80.5m USD
Other Expenses
15.5m USD
Net Income
-65m USD
Fundamental Scores

VYGR Profitability Score
Profitability Due Diligence

Voyager Therapeutics Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
ROE is Increasing
ROIC is Increasing
Negative Revenue Growth Forecast
38/100
Profitability
Score

Voyager Therapeutics Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

VYGR Solvency Score
Solvency Due Diligence

Voyager Therapeutics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Voyager Therapeutics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VYGR Price Targets Summary
Voyager Therapeutics Inc

Wall Street analysts forecast VYGR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VYGR is 13.9 USD with a low forecast of 9.09 USD and a high forecast of 18.9 USD.

Lowest
Price Target
9.09 USD
194% Upside
Average
Price Target
13.9 USD
350% Upside
Highest
Price Target
18.9 USD
512% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Voyager Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for VYGR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

VYGR Insider Trading
Buy and sell transactions by insiders

VYGR News

What is the Intrinsic Value of one VYGR stock?

The intrinsic value of one VYGR stock under the Base Case scenario is 4.62 USD.

Is VYGR stock undervalued or overvalued?

Compared to the current market price of 3.09 USD, Voyager Therapeutics Inc is Undervalued by 33%.

Back to Top